Latest Growth disorders Stories
DALLAS, April 7, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018" therapeutic
LONDON, April 2, 2015 /PRNewswire/ -- SummaryAcromegaly and gigantism are rare disorders of the pituitary gland characterized by the hypersecretion of growth hormone (GH).
ReportsnReports.com adds EpiCast Report Acromegaly and Gigantism Epidemiology Forecast to 2023 to its store.
Arabidopsis plants that only reach half their normal height have a mutation in the biosynthesis of the plant growth factor gibberellin
NOVATO, Calif., Oct. 19 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia.
An indigenous family living in a mountainous area of Malaysian Borneo helped Van Andel Research Institute (VARI) researchers to discover information about genetic mutations associated with acromegaly, a form of gigantism that often results in enlarged hands, feet, and facial features.
LOS ANGELES, June 1 /PRNewswire/ -- Celebrating its 24th anniversary, this year's Sports Spectacular - the premier sports awards gala in the country - will bring together more than 80 of the nation's top athletes with 1800 prominent members of the financial, entertainment, legal and corporate communities from Los Angeles and New York.
The Munchkin is a fairly new breed of cat with a lot of controversy surrounding it. The breed is created by a mutation that causes achondroplasia, or hypochondroplasia, which results in the cats having abnormally short legs. The breed originated when a pregnant, short-legged black cat was discovered in Louisiana in 1983. One of her kittens, a tomcat, became the father of the breeding program for Munchkins. Several cat registries refuse to recognize the breed due to the controversy that...
- A young chicken: also used as a pet name for children.